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1 Executive Summary
Chemical innovation affects almost every aspect of our 
daily life: it affects, for instance, what we eat and wear, the 
structures we live in, how we communicate, how we go to 
work and travel around the world, how we produce and 
store energy and how we diagnose and cure disease. Con-
sequently, chemical innovation is key to improving our 
health and protecting the environment. It will contribute 
to the reduction of our carbon footprint and to the discov-
ery of virtuous resource and energy cycles, paving the way 
towards a truly sustainable economy and society. Chem-
ical innovation is only possible with detailed insights 
into chemical structures and processes. This is what then 
opens the possibility to design novel compounds and ma-
terials and to access sustainable production processes.
Regarding chemical research, Switzerland is among the 
leading nations of the world. This remarkable success re-
sults from the interplay and mutually beneficial relation-
ship between top ranking universities and a strong chem-
ical and pharmaceutical industry. The Swiss chemical 
and pharmaceutical industry generated more than 50% of 
total Swiss exports in the first half of 2020, and is the sec-
ond most competitive worldwide. This economic sector 
directly employs more than 74,000 people in Switzerland 
with another 203,000 jobs in associated branches.
This industry is attracted to Switzerland and is retained 
here because of the world class academic research and ed-
ucation environments arising from the Swiss universities 
of applied sciences, the renowned Swiss universities and 
federal institutes of technology (ETH domain).
Academic research in the chemical sciences is undergo-
ing a profound transition. Characterised by studies car-
ried out at the single laboratory level in the past, research 
is increasingly oriented towards multi-laboratory collab-
orative endeavours in decentralised networks; it also re-
quires access to more advanced tools at highly specialised 
facilities and across disciplinary expertise. This transi-
tion is propelled by the increasing scope and complexi-
ty of chemical problems which today require exchanges 
across classical disciplinary boundaries together with the 
need for research infrastructures that provide state-of-the-
art instrumentation and expertise at the edge and beyond 
the classical boundaries of chemistry.
For decades, the essential infrastructures for chemistry 
research could be provided at single university, insti-
tute or even laboratory level. However, frontier instru-
mentation is no longer affordable to single institutions. 
Not only does cost become prohibitive, but the expertise 
required to develop and operate the instrumentation is 
rare. Furthermore, the complexity of the data generated, 
from acquisition to interpretation, also requires novel ap-
proaches, which is being propelled by the ongoing digital 
revolution where chemistry applications emerge among 
the most demanding today. Consequently, a set of nation-
al hubs/centres are needed to provide state-of-the-art in-
frastructure to all Swiss researchers across the chemical 
sciences and, thereby, maintain Switzerland at the fore-
front of chemical research and innovation.
Following established models, these infrastructure-hubs 
can either be organised as central national facilities, for 
instance around the synchrotron radiation sources today 
offered at PSI, or as distributed networks linking multiple 
sites that host complementary instrumentation and ex-
pertise. All the hubs will be made accessible to research-
ers across Switzerland and developed as international 
centres. Since frontier instrumentation requires specific 
skills for operation as well as specialised expertise for 
data analysis, these hubs will provide both frontier tools 
and expert staff to the broad user community.
Moreover, the proposed infrastructures should foster mul-
tinational scientific exchange and collaboration. Pres-
ently, Switzerland is a member of several international 
research organisations, including CERN, the European 
Synchrotron Radiation Facility (ESRF) comprising the 
Swiss-Norwegian Beamline (SNBL), the European X-Ray 
Free Electron Laser (European XFEL), the European Spal-
lation Source (ESS) and the European Life Science Infra-
structure for Biological Information (ELIXIR). This inter-
national connectedness is crucial for the high quality of 
chemistry research in Switzerland. The national infra-
structures proposed in this roadmap will continue to pur-
sue an international vision, that will also help to attract 
further international talent, foster exchange at the interna-
tional level and develop the international competitivity of 
the Swiss research environment.
This roadmap recommends to set-up or consolidate seven 
national infrastructures grouped into two pillars of dis-
covery- and challenge-oriented infrastructures.
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A first group of discovery-driven infrastructures will pro-
vide essential capabilities for characterisation at different 
temporal and spatial resolutions and to study fundamen-
tal structure-function relationships under relevant condi-
tions, which is at the basis for rational development and 
innovation. This first group comprises:
1. A magnetic resonance and magnetism hub,
2. A centre for operando synchrotron studies,
3. An electron microscopy and diffraction hub.
The second group of infrastructures builds on the insights 
from fundamental structure-function relationship studies 
to tackle major social challenges. These challenge-driv-
en infrastructures are oriented to screen, discover, gener-
ate and develop lead chemicals and materials for specific 
applications related to energy, health and sustainability. 
This second group comprises:
1. A facility to produce Terbium radionuclides for diag-
nostics and treatment of disease,
2. A mass spectrometry-based screening platform for 
(bio)catalysts and environmental samples,
3. A centre providing state-of-the-art instrumentation for 
translational chemistry and managing a national library 
of compounds synthesised in academic laboratories 
across Switzerland,
4. A catalysis hub (CAT  +) to discover and develop cata-
lysts and catalytic processes.
The proposed infrastructures were identified in the course 
of an 18-month process starting in summer 2019. All pub-
lic institutions conducting chemistry research were repre-
sented throughout the process. Moreover, the input from 
chemists across Switzerland was collected in a survey 
conducted by the SCNAT Platform Chemistry and organ-
ised in close collaboration with the Swiss Chemical So-
ciety. The elaboration of this roadmap constitutes an im-
portant first step towards long-term strategic consultation 
and planning within the Swiss chemistry community.
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2 Findings and Recommendations
General Findings
Finding: Frontier instrumentation can often no longer be 
accommodated at a single university or institution, both 
due to cost and because of requirements for highly spe-
cialised advanced skills for operation and data analysis. 
While the user groups have expertise in their specific 
fields of application, they often lack access to the most 
advanced instrumentation and are short on the compre-
hensive skills required to run such instruments and ful-
ly process and analyse the data obtained. Consequently, 
research groups in chemistry now require state-of-the-art 
research infrastructures with well-trained staff.
Recommendation: It is recommended to develop national 
infrastructures accessible to all researchers in Switzerland, 
as well as in other nations, to provide access to advanced 
instrumentation and expertise. Trained permanent staff 
should support and advise users regarding data acquisition 
and data analysis.
Magnetic Resonance  
and Magnetism
Finding: Switzerland is a global 
lea der in magnetic resonance. 
Infrastructure in EPR, magnet-
ic measurements, and high-field 
NMR is essential for the commu-
nity across the whole of chem-
istry, from chemical biology to materials chemistry. Our 
capacity in this area will no longer meet the international 
standards in 5 years from now. Single institutions or local 
consortia can no longer meet this need.
Recommendation: There is the need for the creation of a new 
distributed infrastructure serving the whole Swiss communi-
ty. The infrastructure will maintain international leadership 
in magnetic resonance and support academic and industrial 
research across the chemical sciences.
Centre for operando 
 Synchrotron Studies
Finding: The Swiss chemistry 
and material science communi-
ties have an increasing need for 
multiple-technique beamlines 
for operando synchrotron-based 
studies. However, the present 
shortage of multiple-technique beamlines will not be al-
leviated by the planned upgrades of existing beamlines in 
Switzerland and Europe (SLS 2.0 and ESRF-EBS), which 
aim to further specialise single-technique beamlines. 
Moreover, synchrotron experiments produce increasing 
amounts of complex data generating a need for expertise 
and support for data analysis.
Recommendation: A centre for operando synchrotron stud-
ies localised at two complementary synchrotrons and cen-
tred around multi-technique beamlines should be launched 
to alleviate these bottlenecks. The new centre will exploit 
synergies between multi-technique beamlines at ESRF and 
SLS and provide a gateway between home laboratories and 
the upgraded synchrotron facilities. Moreover, the centre 
should provide expertise tools for data management and 
analysis and provide standardised setups for operando ex-
perimentation to facilitate efficient use of beamtime.
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Electron Microscopy  
and Diffraction
Finding: Electron microscopy (EM) 
is a powerful analytical method 
that can simultaneously provide 
structural, compositional and 
chemical information for com-
plex structured materials at atomic resolution. Recently 
implemented in situ and operando capabilities allow the 
observation of materials under application-relevant con-
ditions. Furthermore, the development of both, highly 
sensitive and very fast detectors as well as pulsed elec-
tron sources, open the door to mechanistic studies of dy-
namic chemical processes and structure determination of 
beam-sensitive substances at the atomic scale.
Recommendation: To establish a distributed electron micros-
copy facility, each of the participating units will provide a 
station offering support, expertise and innovative EM infra-
structure specifically configured for structure determination 
of beam sensitive substances or the study of fundamental 
chemical reactions and processes with frontier space and 
time resolution into material, physical and (bio)chemical 
systems. This unique, decentralised EM facility, building a 
consortium with highest expertise in particular fields of ap-
plications, will provide fundamental and applied knowledge 
in various areas of chemistry and material research.
Radiochemistry: Targeted 
Alpha Therapy using 
 Terbium and Other Oncolog-
ical Solutions (TATTOOS)
Finding: Nuclear medicine uses 
radionuclides for the diagnosis 
and/or treatment of disease. To-
day, radionuclides of highest purity are made available 
at PSI for preclinical and first in-human clinical studies. 
However, some of the desired radionuclides (such as 149Tb 
and 152Tb) are difficult to produce by currently available 
means, but can be produced via ISOL techniques proven 
at CERN. 
Recommendation: A facility at PSI should be extended to 
produce additional radionuclides, in particular the extremely 
promising radionuclides 149Tb and 152Tb. The extended facility 
will allow for performing the entire process onsite, compris-
ing spallation, collection and chemical separation of these 
radionuclides, followed by the production of radiopharma-
ceuticals. Through this facility novel radiopharmaceuticals 




Hub for Chemical Biology
Finding: The competitiveness of 
Swiss academia and the Swiss 
pharmaceutical and chemical in-
dustry builds on the discovery 
and development of powerful 
catalytic entities and their effective and resource-saving 
implementation in challenging syntheses and manufac-
turing processes. To develop sustainable (bio)catalysts, 
fast analysis of samples at miniaturised scale is central. 
Such capacities would be provided by a high-throughput 
screening hub dedicated to apply and further develop 
mass spectrometry-based rapid analysis of chemical enti-
ties, which is currently lacking in Switzerland.
Recommendation: We recommend to create an open access 
high-throughput screening hub to accelerate the develop-
ment of new (bio)catalytic entities and bioactive compounds. 
Embedded at a central location such as the Zurich Univer-
sity of Applied Sciences, the hub will build on cutting-edge 
high-throughput screening technology. In particular, micro-
fluidics and acoustic mist ionisation coupled to mass spec-
trometry will be implemented. 
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National Centre  
for Translational Chemistry
Finding: The ACCESS platform of 
the NCCR Chemical Biology has 
emerged as an important tool 
to harness chemistry research 
in (Swiss) academia to respond 
to societal challenges, particularly public health (for in-
stance, the rapid identification of anti-SARS-CoV-2 drug 
candidates). The number of requested screens has steadily 
increased over the years, especially for translational stud-
ies. However, the NCCR Chemical Biology will expire in 
2022, and the costs to continue ACCESS are too high for 
a single institution.
Recommendation: It is recommended to transform the 
 NCCR-based ACCESS platform into a National Centre for 
Translational Chemistry. Investments are required to signifi-
cantly upgrade the platform, broaden its scope and to assure 
that the top standards applied serve the whole Swiss com-
munity. Through the envisaged National Centre for Transla-
tional Chemistry, Switzerland may also assume leadership 
on the European level.
Catalysis Hub 
Finding: Sustainable development, 
such as producing goods without 
impact on our environment, is 
one of the greatest challenges fac-
ing humankind in the 21st centu-
ry. It will require the acceleration 
of the development and discovery of efficient and sus-
tainable chemical processes using alternative feedstocks. 
In addition, the arrival of robotics and the possibilities 
offered by advanced spectroscopy/microscopy, compu-
tational chemistry and data science, as well as the new 
NCCR Catalysis, offer new opportunities to discover and 
develop catalytic sustainable processes to maintain Swiss 
competitivity in chemical research.
Recommendation: The Catalysis Hub (Cat +) launched in 2021 
should be consolidated to provide the access to state-of-
the-art instrumentation and expertise in high-throughput 
experimentation and data analysis that is needed for the 
Swiss catalysis research community, in both academia and 
industry. This research infrastructure would put Swiss Re-
search on the forefront for the development of sustainable 
chemical processes and digital catalysis discovery.
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3 Introduction
The present roadmap for future large research infrastruc-
tures represents the view of the Swiss scientific communi-
ty in the field of chemical sciences. It is a formal element 
of the process to elaborate the ‘Swiss Roadmap for Re-
search Infrastructures 2023’ according to Swiss law (art. 
41 Federal Act on the promotion of research and innova-
tion; art. 55 of the corresponding ordinance). The roadm-
ap describes the community needs in terms of national 
or international research infrastructures for the funding 
period 2025–2028. It shall serve as an additional basis for 
the decision-making on new or major upgrades of national 
infrastructures and/or major participations in internation-
al network infrastructures and user facilities. 
The responsibility for the elaboration of the ‘Swiss 
Roadmap for Research Infrastructures 2023’ rests with the 
State Secretariat for Education, Research and Innovation 
(SERI). It has thus launched a process that includes (phase 
1) the selection of infrastructures by the ETH Board and 
swissuniversities, (phase 2) the evaluation by the Swiss 
National Science Foundation, and (phase 3) the assess-
ment of the feasibility again by the ETH Board and swis-
suniversities. The result will be submitted to the Feder-
al Council for consideration and decision in the context 
of the Dispatch on Education, Research and Innovation 
2025–2028. This whole process is complemented by a 
preparatory phase to establish the needs of the various 
scientific communities. The SERI has formally mandated 
the Swiss Academy of Sciences (SCNAT) with the elabo-
ration of these discipline-specific community roadmaps 
to which the present one belongs.
SCNAT has initiated the work to elaborate such disci-
pline-specific community roadmaps in the fields of biol-
ogy, geosciences, chemistry, and in sub-fields of physics 
in the last quarter of 2018. Its Board defined a process that 
provided for an overall strategic project lead and for com-
munity-specific sub-projects, all headed by acknowledged 
researchers. The whole process was modelled in analogy 
to the long-standing experience of SCNAT in the fields 
of astronomy and physics, where roadmaps for research 
infrastructures had been elaborated in earlier years by the 
various communities, which were assembled for that pur-
pose around a so-called ‘Round Table’. Accordingly, start-
ing in 2019, such Round Tables were also established in 
biology, chemistry and geosciences. In the past two years, 
hundreds of researchers were invited to take part in this 
process and dozens of them actively participated in each 
of the various Round Tables. Whereas this effort was run 
under the overall responsibility and guidance of SCNAT, 
including the provision of considerable scientific, edito-
rial and administrative manpower by its office, the final 
result must be considered a genuine bottom-up contribu-
tion by the various scientific communities.
The roadmap at hand presents the vision for the future 
development of chemical sciences in Switzerland. During 
the elaboration of the document, all public institutes for 
chemistry research were represented at the Round Table, 
namely the Swiss universities and universities of applied 
sciences as well as the institutions of the ETH domain. 
Starting from key existing infrastructures as well as fields 
of research with potential infrastructural needs, working 
groups were created on eleven distinct topics. In a sec-
ond step, the needs identified by the working groups were 
consolidated to seven proposals for new or major updates 
of existing infrastructures. The consolidation efforts were 
also extended to the other community roadmaps, namely 
the Photon Science and the Neutron Science Roadmaps. 
A video presentation of the proposed infrastructures was 
published online in conjunction with a survey to collect 
the feedback from numerous researchers in chemical 
sciences across Switzerland.
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4 Purpose and scope of this roadmap
Our century is facing many challenges, from immediate 
health concerns to global environmental threats and en-
ergy issues. Our response to these challenges will require 
the identification and development of novel (bio)mole-
cules, materials, and sustainable processes. To this end, 
Swiss researchers in academia and in the world-leading 
chemical and pharmaceutical industry will need to con-
tribute ground-breaking innovations. The recommenda-
tions expressed in this roadmap aspire to provide critical 
elements of the infrastructure required to maintain Swit-
zerland at the forefront of chemical research. 
Ground breaking chemical research requires state-of-the-
art equipment and infrastructures with sufficient support 
from expert staff. Recently, pivotal discoveries were made 
by means of massive screening and high-throughput ex-
perimentation combined with modern data analysis. 
High-throughput screening is used to profile biomolecular 
pathways for large cohorts or to identify chemicals with 
desired properties, for instance potential drug candidates, 
from among innumerable possible compounds. Moreover, 
key developments have also been based on our advancing 
ability to understand the relation between structure and 
function through so-called structure-property relation-
ships. These studies benefit from recent developments in 
analytical tools such as spectrometers and microscopes, 
which have enabled us to observe detailed structures at 
different length and timescales. These insights are critical 
to our ability for rational design and the development of 
novel molecules and materials. In this chemical revolu-
tion Switzerland has certainly been a key player, high-
lighted by its many Nobel laureates and other prominent 
scientists recognised worldwide, as well as its renowned 
chemical industry. 
The last century has seen constant expansion of research 
in the chemical sciences. These endeavours could be con-
fined by and large within small laboratory units at the 
level of professorships and group leaders, where each 
chemist could conceive, test and analyse molecules and 
materials largely independently. However, chemical re-
search is rapidly transforming and today requires access 
to research infrastructure offered by universities (e.g., 
electron microscopy, NMR and X-ray facilities, mass 
spectrometry centres and screening facilities) and in some 
cases national facilities (especially lasers and synchrotron 
radiation sources). While technical advances have led to 
the miniaturisation of many instruments, which can be 
hosted in research laboratories, the frontier instruments 
have now become too costly to be run by a single research 
group or even at university/research institute levels. The 
latter type of infrastructure includes robotised screening 
devices, (bio)molecule databanks and high-end analytic 
devices, such as microscopes and magnetic resonance 
spectrometers. Furthermore, the operation of frontier 
instrumentation and comprehensive analysis of the ob-
tained data require specific expertise outside of the scien-
tific fields of its various users (e.g., applied mathematics 
and physics, data analysis, electronics and informatics).
In order to remain competitive, this ongoing transition of 
chemical research must be supported by the creation of 
open national hubs for frontier experimentation on mol-
ecules and materials. Establishing such hubs and centres 
will be critical to maintain Switzerland at the forefront of 
science and technology in the areas of health, energy and 
sustainable development. These efforts should be direct-
ed at providing access to high-end instrumentation and 
expertise not available at a single university: robotised 
synthesis and experimentation, high-throughput screen-
ing, tools for efficient data banking and data analysis, 
and high-end analytical instruments across a broad range 
of length and time scales. The envisaged changes to the 
chemistry research landscape enabled by these new na-
tional infrastructures are expected to enable discovery 
and rational development to speed up technology trans-
fer. Moreover, they aim at speeding up data standardisa-
tion and, thereby, will contribute to the larger Swiss effort 
for open data. 
To address the bottlenecks identified, the chemistry com-
munity proposes to establish national research infrastruc-
tures divided in two main pillars: the so-called discovery- 
and challenge-driven infrastructures. 
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5 Societal, economic and scientific impact of chemistry research
Chemistry is a fundamental and enabling science that 
synthesises and studies molecules and materials and how 
they interact. Chemical innovation affects all our daily 
lives whether we realise it or not: it affects, for instance, 
what we eat and wear, the structures we live in, how we 
go to work and travel around the world, how we produce 
and store energy and how we diagnose and cure disease. 
Without the accumulated knowledge generated by dec-
ades of research in chemical sciences, many of the every-
day products and services we use today would remain 
unknown or be less effective. Looking forward, research 
is continuously extending our understanding of chemi-
cal principles leading to new discoveries. In this way, re-
search in chemical sciences will help us solve many of the 
future challenges including sustainable energy and food 
production as well as maintaining human and environ-
mental health.
In March 1942, Anne Miller was close to death. In their 
quest to save her, doctors administered an experimental 
drug, penicillin, which had been discovered by Alexan-
der Fleming 14 years earlier. Within hours Miller recov-
ered, becoming the first person in the world to be saved 
by an antibiotic. In the decades that followed, medicinal 
chemistry led to the development of a plethora of addi-
tional antibiotics and potent medicines for a wide range of 
diseases which have saved millions of lives worldwide. In 
Switzerland, the availability of new medicines contribut-
ed to increasing the average life expectancy from 47 years 
in 1900 to 83 years in 2018.
Advancements in biotechnology, genetic engineering and 
the introduction of the Darwinian principles of evolution 
to the laboratory have taught chemists how to access larg-
er molecules and to construct biological entities such as 
antibodies and enzymes with new or improved proper-
ties. Whereas antibodies have been engineered to treat a 
multitude of cancers and autoimmune diseases such as 
rheumatoid arthritis, improved enzymes represent an effi-
cient and environmentally friendly addition to traditional 
chemistry in the production of bulk and fine chemicals, 
biofuels, detergents, consumer products, materials, and 
intermediates for the pharmaceutical industry. 
Chemistry did not only help cure devastating diseases, 
it also contributed to more productive food-growing pro-
cesses necessitated by the increase in the world’s pop-
ulation (1900: ~1.6 billion; 2020: ~7.8 billion). The de-
velopment of an efficient, scalable production process 
of ammonia, which is the world’s primary fertiliser, un-
locked the increase in agricultural output after 1950. More 
recent efforts strive to produce large quantities of agricul-
tural goods in more sustainable ways, applying novel fer-
tilisers and application techniques.
Similar efforts are currently deployed to develop more 
sustainable materials and procedures for various sec-
tors. These efforts are summarised as ‘Green Chemistry’ 
(also ‘Green and Sustainable Chemistry’). Central goals of 
Green Chemistry research are to produce chemicals that 
are non-depleting, non-toxic and non-persistent while 
minimising the environmental footprint of chemical man-
ufacturing processes. Complementary approaches seek to 
replace petrochemicals as the feedstock for chemical syn-
thesis by renewable materials. Such innovations build 
on insights from various fields of chemistry research, in-
cluding the discovery of new synthetic methods, catalyt-
ic agents and alternative reagents. They harbour the po-
tential to transform the industrial production of chemical 
commodities, fine chemicals, agrochemicals and pharma-
ceuticals across the entire value chain from feedstock to 
application.
The ability to harness and store electrical energy is an-
other of the ground-breaking inventions of chemistry that 
have significantly benefitted society. Lithium-ion batter-
ies have revolutionised energy storage and paved the way 
for wireless electronics such as mobile phones, laptops, 
cameras and many other modern applications which 
are inextricably linked to our daily lives. Moreover, ma-
jor steps have been made to improve fuel cells, to estab-
lish hydrogen as an energy carrier, and to provide a CO2 
neutral energy supply for example by solar conversion. 
The rapid progress in these fields has made electric ve-
hicles commercially viable, enabling the current transi-
tion to fossil fuel-free transportation. As the climate crisis 
becomes ever more critical, batteries, fuel cells and the 
production of non-fossil fuel, are among the key technol-
ogies required for the development of cleaner and more ef-
ficient energy storage, contributing to reduced emissions 
of greenhouse gases and, therefore, to a more sustainable 
development and economy. 
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As a direct result of this implication in all aspects of soci-
ety, the economic impact of chemistry research is tremen-
dous. The chemical industry has been a vital sector of the 
modern industrialised economy, and a significant contrib-
utor to the prosperity of the world economy by supporting 
employment and trade. In 2018, the total revenue of the 
global chemical industry amounted to 4.61 trillion euros 
with the global pharmaceutical industry accounting for 
1.26 trillion euros. The chemical industry directly sup-
ported 15 million jobs in 2017, while additional jobs were 
created through the purchases made by the chemical in-
dustry and by subsequent expenditure-induced activities. 
It is estimated that for every person directly employed in 
the chemical industry, seven jobs are supported in other 
sectors of the global economy. 
The Swiss chemical and pharmaceutical industries are 
among the most competitive worldwide. This outstand-
ing competitivity results from consistently high R&D ac-
tivities as well as the growth and high performance of the 
Swiss chemical and pharmaceutical industries in recent 
years. In terms of value creation, the Swiss pharmaceuti-
cal and chemical industries rank 4th and 27th worldwide, 
respectively. The combined sales of the Swiss chemical 
and pharmaceutical market amounted to approximately 
116 billion euros in 2019. In total, the pharmaceutical and 
chemical sectors employ around 74,200 people in Swit-
zerland (full time equivalent, FTE) and create another 
203,000 jobs (FTE) in related branches.
The export earnings of the chemical and pharmaceutical 
industry amounted to approximately CHF 115 billion in 
2019. Contributing more than 40% of total Swiss exports 
annually since 2013, and as much as 53.3% between Jan-
uary and September 2020, this sector is one of the ma-
jor contributors to the Swiss economy. Pharmaceuticals 
(medications, diagnostic products, active pharmaceutical 
ingredients) constitute the lion’s share of these exports 
(more than 80%). Other exported chemicals include or-
ganic products, dyes, agents for crop protection, fragranc-
es, flavours and other food additives. 
In 2018, the total investment in pharmaceutical R&D in 
Switzerland was more than CHF 6.9 billion and the in-
dustry generated around CHF 36 billion in direct added 
value. In addition, Swiss companies in other sectors bene-
fit indirectly from production and research in the pharma-
ceutical industry. Every Swiss franc of value added gen-
erated an additional CHF 0.73 in other Swiss industries. 
As reported in 2018, the total employment effect of the 
pharmaceutical industry amounts to around 254,000 peo-
ple, which correspond to about one in twenty employees 
in Switzerland. 
Research and development are essential to the outstand-
ing performance of the Swiss pharmaceutical sector. In 
addition to financial investments in R&D, Switzerland has 
created and maintained its place as a leader in the chem-
ical sector due to its highly qualified workforce, educated 
at its top-ranking universities, as well as the high level of 
technological and scientific know-how that fosters an in-
novative environment. 
The consequences of chemical research are thus far-reach-
ing, and society has benefited hugely from advances in the 
field. The chemical industry is an important driving force 
for economic growth, which creates opportunities for 
millions of people in Switzerland and around the world. 
Continued investments in chemistry research will ensure 
progress in the development of scientific and technologi-
cal solutions that will help tackle many of the challenges 
we face as a society today.
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6 Landscape analysis
Research infrastructures in the chemical sciences in Swit-
zerland have enabled the leading position of Switzerland 
on a global level for the past decades. From an institu-
tional point of view, these infrastructures are diversely 
located at the research group level, the department level, 
the university level, and finally on a national and inter-
national level, thereby facilitating flexible access to core 
technology to user groups. As a consequence, the research 
infrastructures used by the Swiss chemistry community 
are located throughout Switzerland, both in the cantons 
with and without universities. In addition, some key in-
frastructures are located abroad.
Different organisational frameworks have been developed 
to facilitate operations, ranging from knowledge-based re-
sources that can be hosted on servers, to multi-user dis-
tributed networks and national centres. Examples of 
knowledge-based resources include UniProt, a proteomics 
database co-hosted by the Swiss Institute of Bioinformat-
ics and international partners, and enviPath, a database 
on microbial biotransformation of organic environmental 
contaminants closely tied to Eawag. Distributed networks 
often form around the SNF National Centres of Compe-
tence in Research (NCCR), for example MARVEL (EPFL), 
Chemical Biology (University of Geneva/EPFL), Molec-
ular Systems Engineering (University of Basel/ETH Zu-
rich), Bio-Inspired-Materials (University of Fribourg), and 
Catalysis (ETH Zurich/EPFL). Networks are well-suited to 
share computational tools and expertise for data analysis 
(e.g., the bioinformatics resource portal Expasy). By con-
trast, instruments and analytical devices must be installed 
and maintained in a defined location. At present, many re-
search institutions offer high-end analytical services pri-
marily to local users. In addition, national centres provide 
unique state-of-the-art equipment open to all researchers in 
Switzerland, such as the Swiss Spallation Neutron Source 
(SINQ), the Swiss X-ray Free-Electron Laser (SwissFEL) 
and the Swiss Light Source (SLS) at PSI, as well as the 30 % 
share in two Swiss-Norwegian Beamlines (SNBL) at the Eu-
ropean Synchrotron Radiation Facility in France (ESRF). 
The 2019 Swiss Roadmap for Research Infrastructures lists 
further national infrastructures that will be accessible to all 
Swiss researchers, namely the Neuchâtel Platform of Ana-
lytical Chemistry, a facility dedicated to high-field NMR, 
and the Catalysis Hub. The installation of the NMR facility 
and the Catalysis Hub starts in 2020/2021.
Many of these infrastructures require highly skilled staff for 
operation and can serve as beacons in research and train-
ing. At Swiss institutes of higher education, more than 
7,000 technicians are employed in research and develop-
ment (3,791 FTE). The number of chemistry students in 
Switzerland steadily increased by approx. 23% over the 
last decade. In 2019, 482 students were enrolled in MSc 
chemistry study programmes and 1,147 students were en-
rolled as PhD students in chemistry. The next generation 
of scientists is trained on cutting-edge instruments, and 
will, therefore, obtain key skills for the decades to come. In 
addition, these infrastructures often also attract top talent 
worldwide, and serve the educational aspects of interna-
tional mobility for universities and research centres alike. 
PSI, for example, hosts approx. 5,000 visiting scientists 
from various fields every year, mostly from Switzerland 
and other European countries, who perform experiments 
on PSI’s large research infrastructures.
International connectedness is a decisive ingredient to the 
successful and visible research activities in Switzerland. 
The high exchange of Swiss researchers with their peers 
abroad is reflected by the scientific publications by Swiss 
authors, 85% of which are published together with inter-
national co-authors. Moreover, Switzerland is currently 
member of several international research organisations, 
including CERN, the ESRF including SNBL, the European 
X-Ray Free Electron Laser (European XFEL), the European 
Spallation Source (ESS) and the European Life Science In-
frastructure for Biological Information (ELIXIR). It should 
also be pointed out that these research infrastructures are 
facilitating research on several levels, from single-user ac-
cess to large, multinational and interdisciplinary collabo-
rations (synchrotrons, XFELs, CERN, etc). In particular the 
role of national user laboratories to facilitate internation-
al collaboration cannot be overestimated, and they will be 
key drivers for innovation in the future. 
Virtually all research infrastructures in Switzerland also 
benefit the private sector and enable collaborations with 
companies, thereby improving the competitiveness of the 
Swiss-based economy. These collaborations have direct 
as well as indirect benefits ranging from the outcome of 
measured data to the education and training of future em-
ployees that are well-qualified to succeed on the skills-
based job market of the future. The economic impact of 
research is very strong: The return of public investment 
in research and innovation is estimated at around 20%. 
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Bird‘s eye view of the Paul Scherrer Institute with the SLS in front (photo PSI)
Research infrastructures, especially on the international 
level, require long-term commitments in funding, which 
can often interfere with short-term funding cycles. Thus, 
in order to maintain and to expand the key position of 
Switzerland in terms of infrastructure, the long-term plan-
ning in the context of Swiss roadmaps is welcomed as 
essential. 
15Swiss Academies Reports, Vol. 16, No. 3, 2021

7 Vision for the future
Today, Switzerland is a globally recognised centre for 
chemical research in academia and in industry. To keep 
this leading role, Switzerland must develop the availa-
ble research infrastructure in a strategic and coordinat-
ed manner. This development of research infrastructures 
should support and accelerate the ongoing transition from 
research in single laboratories to cooperative research en-
deavours. The Swiss chemistry community has under-
stood the necessity to join forces to provide access to fron-
tier instrumentation on a national or international level. 
This necessity arises because the full spectrum of state-
of-the-art instruments can no longer be hosted by each 
single institution. Herein, the Swiss chemistry communi-
ty proposes seven research infrastructures that will help 
to keep Switzerland at the forefront of chemical research 
and innovation.
Chemical research and innovation is key to translate 
knowledge into solutions to current global challenges. In 
particular, scientific discoveries are anticipated that will 
allow us to tap renewable energy sources, improve energy 
storage, protect the environment, improve human health 
and implement sustainable, effective manufacturing pro-
cedures. 
Chemical research contributes to these new solutions 
in two ways: The first pillar of discovery in chemical 
sciences is the study of fundamental structure-function 
relationships. The second pillar is the identification of 
compounds and materials for well-defined purposes. It 
combines fundamental insights on structure and function 
with the screening of compounds and materials for specif-
ic applications. Both pillars of chemical research require 
complementary, dedicated infrastructures.
 
The ‘discovery-driven research infrastructures’ supporting 
the first pillar will provide essential capabilities to charac-
terise molecules and materials at different spatial and tem-
poral resolutions, and to determine the fundamental struc-
ture-function relationships that provide the basis of rational 
development and innovation. The Swiss chemistry commu-
nity has identified the need to create or consolidate three 
infrastructures of this kind:
1. A magnetic resonance and magnetism hub,
2. A centre for operando synchrotron studies,
3. An electron microscopy and diffraction hub.
The ‘challenge-driven research infrastructures’ supporting 
the second pillar are oriented to screen, discover, generate 
and develop lead chemicals and materials for specific ap-
plications related to energy, health and sustainability. The 
Swiss chemistry community has identified the need to cre-
ate or consolidate four infrastructures of this kind:
1. A facility to produce Terbium radionuclides for diagnos-
tics and treatment of disease,
2. A mass spectrometry-based screening platform for (bio)
catalysts and environmental samples,
3. A centre that provides state-of-the-art instrumentation 
for translational chemistry and manages a national li-
brary of compounds synthesised in academic laborato-
ries across Switzerland,
4. A catalysis hub (CAT +) to discover and develop catalysts 
and catalytic processes towards a sustainable society.
All of these research infrastructures should be organised as 
central national facilities or as distributed networks joining 
multiple sites that host and develop complementary instru-
mentation and offer expertise in specific areas as well as 
data science. All of the infrastructures will be established 
and managed by at least two closely collaborating universi-
ties or research institutions except for the radiochemistry fa-
cility and the high-throughput screening hub, which foresee 
a single research institution in charge. Irrespective of their 
organisation, all hubs will be made accessible to research-
ers across Switzerland and beyond, from academia and the 
private sector. One of the missions of the hubs will also be 
support the user community with expert staff for data ac-
quisition and analysis. The infrastructures will also provide 
educational opportunities, in particular to PhD students, who 
will be able to perform advanced research experiments in 
collaboration with experts from various universities across 
Switzerland.
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The Swiss chemistry community proposes three discovery-driven research infrastructures 
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Schematic representation of the core techniques in the magnetic resonance infrastructure, and the connection 


























7�1 Capability- and discovery-driven research  
 infrastructures
Infrastructure of this kind provides the enabling tools that 
allow us to design, model, synthesise, characterise and 
test molecules and materials at different length and time 
scales (from atomic scale through to meso-scale compo-
nents). These tools enable the determination of detailed 
and precise structure-property relationships, and thereby 
propel discovery and rational development. This type of 
infrastructure includes large-scale, campus-based, open 
facilities as well as distributed and often international-
ly-based state-of-the-art infrastructures and major univer-
sity-based clusters of capability, e.g., SLS at PSI.
7�1�1  Magnetic Resonance  
 and Magnetism
Context (national and international), 
scientific rationale and challenges 
Magnetic resonance techniques, 
such as nuclear magnetic reso-
nance (NMR) and electron para-
magnetic resonance (EPR) spectroscopies, are indispen-
sable for structural characterisation of biological systems 
and materials on length scales between a fraction of the 
length of a chemical bond and about 10 nanometres, and 
for their characterisation of dynamics on time scales from 
picoseconds to hours. For condensed, non-crystalline 
matter, NMR and EPR provide unparalleled probes. For 
magnetic molecules and materials, they are complement-
ed by measurements of magnetism, for instance, with su-
perconducting quantum interference devices (SQUID).
The complexity of biochemical systems and materials un-
der investigation at the forefront of science continuously 
increases. This development can only be supported in the 
longer run if techniques for the characterisation of struc-
ture and dynamics keep pace. In NMR this has notably 
been the driving force for the push to higher and high-
er magnetic fields. We see today that especially for sol-
ids and for chemistry in cells, NMR and EPR still have a 
great potential for further methodological developments 
and applications. In NMR, this development continues 
to focus internationally to a large extent on overcoming 
the main Achilles’ heel of the technique, which is low 
sensitivity. Significant progress has been made in the 
past decade with dynamic nuclear polarisation (DNP) ap-
proaches, which would benefit from combined NMR and 
EPR infrastructure, as they rely on paramagnetic species 
as a polarisation source for nuclear spin transitions. For 
EPR spectroscopy, novel fast electronics and microwave 
technology, currently under development for communi-
cation systems, enables largely digital spectrometers and 
consequently development of much more complex meas-
urement schemes than are currently available.
Switzerland is a leading country in magnetic resonance, 
with two Nobel laureates in the field and with the lead-
ing instrument manufacturer being based in Switzerland. 
Foundational textbooks have originated in Switzerland, 
and groups especially at ETH Zurich, EPFL, and the Bio-
zentrum in Basel, are internationally highly respected in 
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Advanced instrumentation for magnetic resonance, here featuring 
the world-wide unique 900 MHz gyrotron DNP NMR spectrometer at EPFL, 
has always enabled new discoveries in applications across the chemical 
sciences, and will continue to do so in the future 
(photo Lyndon Emsley, EPFL)
the field and currently very well equipped. Major invest-
ment in high-field NMR spectrometers and DNP instru-
ments is being made internationally, in particular in Chi-
na, but also in Germany, the USA, France, the UK and 
Italy. In the USA and in the UK in particular, NMR groups 
are complementing their portfolio with advanced EPR 
spectroscopy to measuring distance distributions in the 
nanometre range. Until now, Switzerland has been able 
to invest in frontier NMR and EPR at the institutional lev-
el. However, with the next generation of NMR magnets 
costing around 15–20 MCHF, this will no longer be pos-
sible. Indeed, the acquisition of the 1.2 GHz NMR sys-
tem for structural biology, included in the 2019 Roadmap 
for Research Infrastructures, required co-funding by ETH 
Zurich, University of Zurich, University of Basel and the 
SNSF. This system, dedicated to research in structural bi-
ology, has now been installed in 2020 and is in the test 
phase. There is no equivalent national capacity for chem-
istry focused high-field NMR, and there is now a clear 
danger for Switzerland to be left behind, if the country 
does not continue to develop and invest in shared nation-
al infrastructures for NMR and EPR. 
Aims of the Proposed Infrastructure
While state-of-the-art NMR infrastructure is today acces-
sible to some extent at all leading Swiss universities, ad-
vanced EPR infrastructure with the capability to support 
projects in life sciences, materials sciences, and catalysis 
currently exists only at ETH Zurich. The latter infrastruc-
ture was created for research on EPR method develop-
ment. It is neither sufficient nor well adapted for cater-
ing to the needs of researchers in application fields for 
all of Switzerland. As discussed above, next generation 
high-field NMR instrumentation for chemistry will be be-
yond the reach of single institutions. Instrumentation for 
magnetisation measurements is only locally available to 
individual research groups or small clusters of research 
groups. 
We propose to establish two Swiss shared application fa-
cilities for magnetic resonance and magnetism, one at ETH 
Zurich and one at EPF Lausanne to cater for the needs of 
Swiss universities. The establishment of two centres capi-
talises on the specific expertise of the strong local research 
groups that will lead the infrastructures, and allows for 
specialisation.
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Storage ring of the Swiss Light Source (SLS) at PSI (photo PSI)
7�1�2 Centre for operando 
Synchrotron Studies
Context (national and international), 
scientific rationale and challenges 
Understanding the geometric and 
electronic relations between struc-
ture, property and performance is 
crucial for the rational design of new molecules and mate-
rials and thus for the discovery and optimisation of chem-
ical and physical processes of fundamental or practical 
interest. The chemical sciences not only require experi-
mental tools probing structure at different length scales, 
from atomic to nanometre to mesoscopic, but also, very 
importantly, under relevant conditions where the investi-
gated molecule, material or process is functioning/work-
ing (so-called in situ and operando) conditions. X-ray 
based methods are among the most powerful methods for 
studying structure under such ‘working’ conditions. As 
synchrotron light sources provide orders of magnitude 
higher brilliance in comparison to conventional X-ray 
sources, they are the facilities of choice for real time X-ray 
based structural studies.
Various complementary synchrotron-based X-ray tech-
niques (see textbox) are used by the chemistry and ma-
terial science communities to study compounds and ma-
terials, material synthesis or reaction mechanisms under 
operating conditions in devices or cells utilising the high 
penetration depth of hard X-rays. These communities 
profit from the local proximity of competitive state-of-the-
art single technique beamlines at the Swiss Light Source 
(PSI, Villigen) as well as the European Synchrotron Radi-
ation Facility (Grenoble, France), where the Swiss-Nor-
wegian beamline has been tuned to the need of chemists. 
The techniques most extensively used by the communi-
ty are XAS, total scattering and XRD. The Swiss chemis-
try and materials science community that needs access 
to synchrotron facilities is rapidly growing, and address-
es questions of increasing complexity. This has revealed 
four principal challenges during the last five years: First, 
novel materials exhibit unprecedented complexity, which 
necessitates appropriate combinations of synchrotron 
techniques to elucidate their properties. This requires a 
multi-technique approach under true working conditions 
(an approach that has been pioneered at the Swiss-Norwe-
gian Beamlines at ESRF). Second, at synchrotron facilities 
worldwide, there exists a significant delay between pro-
posal writing and assigned beamtime, typically of at least 
4–5 months. Furthermore, only around 30% of proposals 
are accepted and allocated beamtime, strongly supporting 
the need for an increase in capacity. Third, the major bot-
tleneck is increasingly the large amount of data produced 
on experimental stations, which can easily amount to sev-
eral TB of data per day. Data processing, storage and anal-
ysis nowadays requires expert support. The fourth chal-
lenge concerns the reproducibility and transferability of 
experiments between the home laboratories and synchro-
tron beamlines, and also between different beamlines. 
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Experimental set-up for X-ray absorption and emission spectroscopy 
with enhanced chemical sensitivity and time resolution (SuperXAS) 
(photo Maarten Nachtegaal, PSI)
Techniques for real time X-ray based structural studies at 
synchrotron light sources include:
 — High resolution X-ray diffraction (XRD) providing precise in-
formation on the complete atomic-level structure in crystal-
line materials.
 — X-ray total scattering provides information on local structures 
up to a few nanometres, for materials with or without long-
range order.
 — Diffuse scattering for single crystals provides structural infor-
mation at the nano-scale, as do high resolution X-ray diffrac-
tion and X-ray total scattering.
 — X-ray absorption spectroscopy (XAS) provides information on 
the local atomic-level structure up to 6 Å around the element 
of choice, and on the oxidation state of the element.
 — X-ray emission spectroscopy (XES) provides electronic infor-
mation on the filled density of states including valence elec-
trons and spin state. 
 — Resonant X-ray emission spectroscopy (RXES or RIXS) com-
bines XES and XAS in one experiment and provides full infor-
mation on electronic structure(s).
 — Near ambient X-ray photoelectron spectroscopy (XPS) pro-
vides surface sensitive information on the chemical and elec-
tronic state of elements.
 — Small angle X-ray scattering (SAXS) provides information on 
nano and mesoscopic scales such as the size and shape of 
nanoparticles, density fluctuations and order therein.
New developments in laser-based X-ray spectroscopy could 
potentially lead to laboratory-based setups that cover some 
of these techniques, albeit at lower time-resolution com-
pared to synchrotron-based X-ray spectroscopy. Free elec-
tron X-ray lasers, such as the new SwissFEL at PSI, provide 
access to many of these techniques on the femto- to pico- 
second time scales, and might therefore become a relevant 
tool for fundamental chemistry research and beyond in the 
decades to come. 
Aims of the Proposed Infrastructure
Aiming to alleviate all of the aforementioned bottlenecks 
and challenges, a centre for operando studies comprising 
two complementary hubs is proposed. The centre should 
capitalise on existing facilities and committed future in-
vestments. The West Hub will consist of the two SNBL 
beamlines (30% Swiss share at ESRF). The East Hub will 
consist of the projected Debye beamline, as well as shares 
of other single technique SLS beamlines and complimen-
tary operando IR/Raman/UV setups available at PSI. As 
both synchrotrons have been or will be upgraded to a dif-
fraction limited light source, these facilities will remain at 
the forefront of X-ray science. The upgraded light sources 
will remain complementary in terms of the provided en-
ergy range, brilliance and beam type (focused vs. unfo-
cused). The need for combined technique beamlines (with 
emphasis on XAS and XRD) has grown rapidly, as has the 
need for direct and rapid access for high impact science 
and industry to these resources. To fulfil this need, SNBL 
at ESRF has recently been upgraded and offers access to 
very high X-ray energies used for complex combined ex-
periments. Furthermore, an additional new beamline, the 
Debye beamline, has recently been funded by the ETH 
domain and is to be constructed at SLS by 2023 for high 
throughput combined experiments. 
The backbone of the proposed centre is comprised of five 
elements:
1. (synchrotron) instruments dedicated to operando X-ray 
diffraction and spectroscopy, 
2. X-ray techniques and their combinations focused on ob-
taining crystal, molecular, atomic and electronic struc-
tures, 
3. setups for in situ and operando experimentation com-
patible with synchrotron instrumentation, 
4. data management and data analysis tools facilitating ef-
fective use of synchrotron beamtime, 
5. direct beamtime allocation, rapid access, mail in service 
and remote access models.


















Organisational chart of the proposed microscopy network (Rolf Erni, Empa)
7�1�3 Electron Microscopy  
and Diffraction
Context (national and international), 
scientific rationale and challenges 
Transmission electron microsco-
py (TEM) has become an indis-
pensable tool in life and physical 
sciences. It is capable of providing simultaneous struc-
tural, compositional and chemical information about 
complex structured materials at atomic resolution. While 
direct atomic-scale imaging has immediate impact on sci-
entific progress in nano- and materials sciences, it is not 
universally applicable. Especially with respect to chem-
istry and life science, the requirement of a high vacuum 
in the microscope has, for a long time, limited the ability 
to study materials in their natural or application-relevant 
environments. Furthermore, the use of strongly interact-
ing electrons for the imaging process limits the possibili-
ty to study electron beam-sensitive materials. The Nobel 
prize in Chemistry in 2017, which was awarded for the 
development of cryo-TEM, highlights the importance of 
minimising radiation effects and of preserving the native 
state of the structure under investigation.
Recent hardware developments have unlocked three re-
search fields for the application of electron microscopy 
which are highly relevant in chemistry: 1) in situ and op-
erando capabilities, 2) time resolution and 3) structure de-
termination for sub-micrometre sized crystals.
1. With the development of commercial instruments and 
tools for in situ scanning electron microscopy (SEM) 
and TEM, it has become possible to investigate sam-
ples under well-defined in situ and operando condi-
tions. With regards to chemistry, the ability to follow 
dynamic processes caused by the interactions between 
a sample and its gaseous or liquid environment at near 
atomic resolution is a breakthrough. It can potentially 
revolutionise our understanding of (electro-)catalysis, 
chemical energy storage and conversion, interfaces, 
material synthesis and evolution. 
2. In addition to the determination of the local geometric 
and electronic structure of samples (the latter through 
electron energy loss spectroscopy) in their relevant en-
vironments, time resolution is crucial for studying dy-
namic processes. New detection strategies based on 
‘noise-free’ ultra-fast direct electron detectors have 
boosted the sensitivity and dynamic range of detectors 
and increased their speed from several frames per sec-
ond (fps) to several thousand fps. Owing to the faster 
and more efficient signal detection, beam exposure 
can be reduced and swift changes can be captured. 
Furthermore, this development opens the door to elec-
tron ptychography and 4D scanning TEM methods. 
For many dynamic processes, acquisition speeds in 
the low micro-second range are still far too slow. With 
the application of a pulsed-electron beam, which al-
lows for imaging with individual, well-defined elec-
trons or electron bundles (ultra-fast electron microsco-
py), the temporal resolution in nanoscale observations 
can be extended to the sub-nanosecond regime.
3. Another important aspect in chemistry concerns struc-
ture determination, particularly in pharmaceutical 
chemistry. While X-ray diffraction is the method of 
choice for micrometre-sized crystals, structure deter-
mination of smaller crystals has been a challenge. The 
combination of real-space imaging to find sub-micro-
metre sized crystals and electron diffraction for their 
structural analysis is a strong asset of TEM. Electron 
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Formation of nanoparticles by liquid-phase scanning transmission electron microscopy (photo Debora Keller, Empa)
nano-crystallography has, therefore, been recognised 
as one of the ten most relevant scientific breakthroughs 
of 2018 by the journal Science. The technique enables 
full structure determination, including hydrogen atom 
positions, of sub-microscopic crystals at minimal elec-
tron doses. It is thus ideally suited for structural inves-
tigations of pharmaceutical compounds and, for exam-
ple, the identification of polymorphs of drugs. 
Moreover, novel applications for studying non-crys-
talline samples by single molecule diffraction are un-
der development. 
For Switzerland’s research in chemistry and in light of the 
local (pharmaceutical) companies and the future energy 
agenda, it is important to remain at the forefront of the 
developments in electron microscopy. It is also important 
to work in close collaboration with Swiss companies that 
provide leading technologies in this area, such as high-
speed, ‘noise-free’ direct electron detectors. 
Aims of the Proposed Infrastructure
The aim of the proposed decentralised infrastructure is 
to implement advanced electron microscopy modalities 
in order to a) realise in situ and operando observations of 
(dynamic) chemical reactions and b) establish platforms 
for structure determination, particularly with a focus on 
pharmaceutical chemistry. These goals can be achieved 
by implementing a set of complementary, dedicated high-
end electron microscopes, each embedded within an exist-
ing facility with corresponding expertise. The dedicated 
electron microscopes will be located across Switzerland 
in a five-hub network based on existing facilities. Each 
hub will have specific capabilities and a primary research 
focus, namely catalysis, electrochemistry, ultra-fast im-
aging, structure determination and in situ scanning elec-
tron microscopy, where the different research modalities 
uniquely benefit from the locally established expertise.
The Swiss microscopy network will consist of the following 
five hubs:
Hub 1: Catalysis. An advanced analytical (scanning) transmis-
sion electron microscope with gas-cell and environmental 
capabilities dedicated to in situ research on catalysts, in-
cluding direct electron detectors, spectrometers, gas anal-
ysis and possibly protection of critical microscope parts to 
probe reactive environments in the microscope. Proposed 
location: ETH Zurich.
Hub 2: Electrochemistry. An advanced analytical (scanning) 
transmission electron microscope with liquid-cell and elec-
trochemistry setups dedicated to in situ research activities 
in the areas of batteries and corrosion. Proposed location: 
Empa.
Hub 3: Ultra-fast imaging. An advanced (scanning) trans-
mission electron microscope with a laser-pulsed or sin-
gle-electron-controlled electron source for studying chemi-
cal reactions at the nano-scale with nano-second resolution, 
combined with advanced detection technologies, spectrom-
eter and energy filter. Proposed location: EPFL.
Hub 4: Structure determination. An advanced cryo- (scanning) 
transmission electron microscope equipped with a) advanced 
direct electron detectors for electron diffraction, backed-up 
by b) advanced computational resources for ptychographic 
reconstructions and c) dedicated to structure determination 
of crystals that are too small to allow for X-ray diffraction 
analysis. Proposed location: PSI.
Hub 5: Dedicated in situ SEM providing an improved base 
pressure in high-vacuum mode and the ability to work up to 
pressures of 0.5 bar in the in situ mode, including a gas-feed-
ing station, mass-spectrometer, heating stage and a variety 
of complementary electron and X-ray detectors, particularly 
complementing Hub 1. Proposed location: EHT Zurich.
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Essential steps for the production of radiopharmaceuticals from the generation of radionuclides to the synthesis of therapeutic agents 
for clinical applications (Nicholas van der Meulen, PSI)
Irradiation Mass Separation Radiochemistry Quality Control Clinical Application 
7�2 Application- and challenge-driven research  
 infrastructures
These infrastructures have an identifiable direct relevance 
to industrial sectors or end-user groups within the econ-
omy such as the pharmaceutical, chemical, crop protec-
tion, and materials industry in Switzerland and beyond. 
The complexity of the user problems will often require 
these infrastructures to be used in concert with other in-
frastructures. These infrastructures tend to be part of wid-
er initiatives targeted towards addressing major scientif-
ic, technical, innovation, societal or policy challenges for 
which additional government funding has been commit-
ted, for example the Swiss Competence Centre for Energy 
Research (SCCER). They often build on outstanding, ex-
isting capability which has been built up over many years 
through capability-driven investments.
7�2�1 Radiochemistry: 
 Targeted Alpha Therapy 
using Terbium and Other 
Oncological Solutions
Context (national and international), 
scientific rationale and challenges 
Nuclear medicine uses radioactive elements, or radionu-
clides, for the diagnosis and/or treatment of disease. The 
decay of each radionuclide is unique, and the type of radi-
oactive decay it undergoes dictates what medical purpose 
the radionuclide can be used for. The chemical nature of 
the radioactive element determines how it binds to a spe-
cific biological molecular target which, in turn, determines 
how it is taken up in the tumour. Furthermore, elements 
containing multiple radionuclides that undergo different 
types of radioactive decay, called ‘sister’ nuclides, are of 
particular interest for radiopharmaceutical applications. 
The use of sister nuclides ensures that tissues can be both 
identified diagnostically and treated with the appropriate 
radioisotope (known as theragnostics).
Terbium is unique in that it exhibits four interesting sis-
ter radionuclides applicable to all the modalities used in 
diagnostic and therapeutic nuclear medicine: 155Tb gam-
ma-ray emission makes it suitable for Single Photon Emis-
sion Computed Tomography (SPECT) imaging. 152Tb emits 
positrons, which is useful for Positron Emission Tomogra-
phy (PET) imaging. 161Tb and 149Tb emit radiation which 
is effective for cancer therapy. These four radioisotopes 
allow to prepare chemically identical radiopharmaceu-
ticals with identical pharmacokinetic profiles. This is a 
unique situation that could serve the concept of person-
alised medicine. 
The aim of this venture is to make all four Tb sister nu-
clides available throughout Switzerland, as well as 
abroad, for the preparation of radiopharmaceuticals in 
view of clinical translation.
The Tb radioisotopes are seen as the ‘lighthouse’ project 
towards this goal. Other novel radionuclides for therag-
nostics can be produced using the envisaged ISOL proce-
dure. The production capabilities can be extended in the 
future using UCx/ThCx targets to produce 𝛼–emitting nu-
clides, e.g., 211At, 223Ra and 225Ac. Moreover, 67Cu and 47Sc 
are also envisaged as potential therapeutic radionuclides 
towards matched-pair theragnostics.
Generally, the availability of an irradiation station with 
high-energy protons at PSI, at the heart of this infrastruc-
ture, will considerably enlarge the radionuclide produc-
tion portfolio. The spallation process induced by high-en-
ergy protons utilising various target material grants access 
to a plethora of exotic radionuclides not otherwise acces-
sible. Separated at unprecedented amounts, these exotic 
radionuclides have great scientific potential for nuclear 
physics, astrophysics and fundamental radiochemistry. 
The infrastructure will also serve users from other areas, 
such as physicists performing basic research at ISOLDE 
(CERN) who may have the opportunity to obtain radio-
nuclides at activities not achieved previously, due to the 
increased beam intensity available at the PSI site. Astro-
physicists can benefit in a similar manner.
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Facility for Isotope Separation On-Line (ISOL) at CERN (photo Noemí Carabán, CERN)
This proposed infrastructure will form part of a larger pro-
ject for nuclear physics research at PSI’s High Intensity 
Proton Accelerator (HIPA) complex, which also involves 
an upgrade of a muon target station situated in close vi-
cinity of the proposed infrastructure.
Aims of the Proposed Infrastructure
In order to reach the goal of making all four Tb sister nu-
clides available for clinical applications, researchers with 
expertise in different disciplines (physics, radiochem-
istry, radiopharmacy, radiobiology, nuclear medicine) 
need to work closely together. The production facilities 
for 155Tb and 161Tb, including chemical separation meth-
ods, modules and laboratories for the GMP synthesis of 
radiopharmaceuticals, are being implemented at PSI. PSI 
has the capability of producing therapeutic 161Tb, utilis-
ing its SINQ neutron source (with collaborators in Europe 
and Africa), while 155Tb will be produced at HIPA in the 
near future. However, production facilities for the remain-
ing two Tb sister nuclides (149Tb and 152Tb) have yet to be 
established. 149Tb and 152Tb can be produced via Isotope 
Separation On-Line (ISOL) techniques as proven at CERN. 
The facilities at PSI should be expanded by an ISOL facil-
ity. It is envisaged to perform the entire spallation, collec-
tion and chemical separation process (developed at PSI) 
for these two radionuclides, followed by the production 
of radiopharmaceuticals onsite (currently expressed as 
Targeted Alpha Therapy using Terbium and Other Onco-
logical Solutions – TATTOOS). 
The products from the new ISOL facility can be trans-
ferred to the GMP facility on the same site (at the Centre 
of Radiopharmaceutical Sciences – CRS), which are then 
used for the labelling of biomolecules. From there, the re-
sultant radiopharmaceuticals will be transported to im-
aging and therapy centres for patient applications. There 
is a unique opportunity at PSI to produce and process ra-
dionuclides at the same site, which will be particularly 
important for the relatively short-lived 149Tb (T1/2= 4 h). 
PSI will become the only facility worldwide that combines 
all essential steps for the production of radiopharmaceu-
ticals: the generation of radionuclides by means of proton 
activation, neutron activation, and spallation reactions, 
mass separation of the generated radionuclides, their in-
corporation into desired compounds by radiochemical 
means, and finally the production of radiopharmaceuti-
cals therefrom. The facility will assist basic research and 
application studies as part of a ‘bench-to-bedside’ prin-
ciple. 
The respective radiopharmaceuticals will be made avail-
able especially to therapy centres, enabling first clinical 
studies throughout Switzerland. Swiss medical centres 
can benefit in particular, as the short half-life of 149Tb lim-
its its logistic capability for therapeutic use: The distance 
between the site of production of the radionuclide and the 
medical centres, where the patients are treated, should be 
as short as possible for an optimal therapeutic effect. 























High-throughput (bio)catalyst library design, construction and screening leads to improved catalytic entities for potent 
and sustainable chemical processes (Rebecca Buller, ZHAW)
7�2�2 High-Throughput 
Screening Hub  
for Chemical Biology
Context (national and international), 
scientific rationale and challenges 
Many, if not all, chemical and bio-
chemical experiments require that 
a meaningful, reliable read-out (analysis) of the generated 
data can be performed. In many chemical and biological 
disciplines, an additional imperative is that high num-
bers of samples need to be analysed rapidly, preferably 
using low sample volume (nL), to save time and resourc-
es. For example, drug discovery efforts rely on the abili-
ty to analyse compound libraries consisting of millions 
of molecules in a fast and reliable way. Consequently, 
high-throughput screening (HTS) is of utmost importance 
when looking into the timely discovery and development 
of new drug candidates for existing and emerging disease. 
In addition, HTS has high relevance in chemical biolo-
gy. When considering enzyme engineering, in which a 
biological catalyst is tailored toward catalysing an indus-
try-relevant reaction, it is desirable to screen more than 
a million reaction samples in a matter of days to identify 
improved biocatalysts for sustainable chemical manufac-
ture. Furthermore, monitoring environmental quality, as 
well as industrial chemical processes, ideally provides 
spatially and temporally resolved chemical data in situ to 
allow real-time control of detrimental factors. 
Today, bottlenecks in compound screening and (bio)cat-
alyst development often lie in sample preparation and 
data analysis. An additional issue is cost per sample, as 
conventional analysis techniques require non-negligible 
amounts of supplementary chemicals in each experiment. 
To address this challenge, current development efforts of 
consortia consisting of pharmaceutical (e.g., Merck, As-
traZeneca and others) and technical companies (e.g., Lab-
cyte, Waters and others) have yielded the technology of 
acoustic mass spectrometry, a combination of acoustic 
mist ionisation (AMI) and mass spectrometry (MS) that 
has the potential to reduce both cost and cycle time due to 
low sample volumes (nL) and rapid measurement cycles 
(sec). This technology can be complemented by systems 
which couple solid phase extraction with mass spectrom-
etry giving access to fast (sec) and robust assay develop-
ment capabilities and allowing to measure an even wider 
molecular diversity. Further automation can be offered by 
microfluidic devices which can create, assay and sort mi-
croscale samples by the generation of nanoscale reactors 
in droplets which can house, for example, single cells. 
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The mass spectrometry-based high-throughput instrumentation at the core of the ‘Screening Hub for Chemical Biology’ will allow to overcome current 
bottlenecks in (bio)catalyst development and environmental sample analysis (Rebecca Buller, ZHAW)
Today, microfluidic devices typically rely on fluorescent 
properties of the analyte to sort the droplets. Consequent-
ly, the instruments are unsuitable for many real-world 
applications dealing with non-fluorogenic compounds. 
However, first prototypic examples highlight the possibil-
ity to couple microfluidic devices to high resolution MS-
based analyses, thus extending the current application 
scope of microfluidics considerably.
Looking forward, an extension of these fast analysis tech-
nologies to encompass also chiral information is desir-
able, for current chiral analysis is much slower (in the 
range of minutes). In addition, further improvements in 
overall instruments robustness, resolution and the estab-
lishment of reliable and sensitive quantification protocols 
at low volume are targeted. 
Aims of the Proposed Infrastructure
The introduction of a ‘Screening Hub for Chemical Biol-
ogy’ infrastructure aims to reduce existing bottlenecks in 
the development of new (bio)catalysts and bioactive com-
pounds, both in terms of cost and throughput. The infra-
structure will be key in the development of novel catalysts 
for sustainable production processes and novel products 
in the Swiss chemical industry. Conceptually, it is placed 
upstream of the ‘National Centre for Translational Chem-
istry’ (NCTC) also proposed in this roadmap, and comple-
ments NCTC’s efforts in the determination of biological 
activity of small molecules. In addition, the Screening 
Hub for Chemical Biology will support environmental 
quality monitoring, such as water quality control, for 
which high-throughput analysis is important. To further 
improve the technological readiness of high-throughput 
devices, available prototypes will be developed in con-
stant dialogue with academic and industrial partners. 
Research efforts will target more robust instruments and 
new protocols that help to solve current challenges such 
as the rapid chiral analysis and reliable quantification at 
nanolitre scale. 
The ‘Screening Hub for Chemical Biology’ can be embed-
ded into the Competence Centre of Biocatalysis (CCBIO) 
at the Zurich University of Applied Science. Moreover, it 
would tie in seamlessly with the automated (bio)catalyst 
development infrastructures already in place (Catalyst 
Hub at ETH Zurich and CCBIO at ZHAW). In addition to 
academic users, Swiss industrial partners and start-ups 
will be able to access the instruments to leverage the state-
of-the-art infrastructure and technical know-how further 
fuelling Switzerland’s vibrant biotechnology and pharma-
ceutical sector. 
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High-throughput screening facility at EPFL (photo BFS-ACCESS EPFL)
7�2�3 National Centre for 
Translational Chemistry
Context (national and international), 
scientific rationale and challenges
We propose to build a nation-
al multidisciplinary centre to 
provide the scientific community in Switzerland with: 
Chemical diversity, screening platforms at the EPFL and 
the University of Geneva, know-how in chemical genetics 
and expertise in medicinal chemistry for drug discovery, 
chemical biology and systems biology-related projects. 
The scope includes screening large chemical libraries 
for other application areas such as sustainable chemis-
try-related projects. The National Centre for Translational 
Chemistry (NCTC) will give access to a national reposi-
tory of chemical collections, composed of a unique col-
lection of molecules synthesised in Swiss academic labs 
in addition to more than 100,000 commercially available 
compounds. 
This public screening centre with unique knowledge and 
expertise will perform screening projects for translation-
al research countrywide for a broad range of assays. The 
screening centre masters state-of-the art technologies and 
innovative methods implemented or developed for de-
signing a variety of tests in the search for active mole-
cules. The tests offered cover the classic pharmaceutical 
target-based in vitro biochemical assays and innovative 
phenotypic image-based cellular assays using relevant 
cell types and physiologically relevant cellular models 
(i.e., models derived from stem-cells and organoids). 
The vision of NCTC will focus on translational research 
though the development of existing infrastructures to-
wards a complete academic drug discovery setting. The 
new centre will address public health challenges in var-
ious therapeutic areas not necessarily addressed by the 
pharmaceutical industry, and perform chemical screen-
ing and medicinal chemistry campaigns. The capabilities 
offered will be beneficial for chemical biology and life sci-
ence research in general as well as investigations in other 
fields, including studies on environmental sustainability.
This major infrastructure could capitalise on pioneer-
ing efforts in Switzerland, namely the project ACCESS 
(an ACademic ChEmical Screening platform for Swit-
zerland) created by the NCCR Chemical Biology1, which 
is equipped with significant instrumental infrastructure 
and know-how in place and which has achieved relevant 
successes over the years (expires end 2022). The ACCESS 
platform of the NCCR Chemical Biology is receiving an 
increasing number of screens, no longer originating exclu-
1 https://nccr-chembio.ch/projects/project5
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Academic Screening Platform for Switzerland (ACCESS) 
(photo ACCESS Geneva)
sively from the host institutions of the platform, EPFL and 
the University of Geneva. 30% of the requests for screens 
come from other Swiss universities.
To build on these rewarding investments and ensure long-
term, sustainable excellence in chemistry, chemical biol-
ogy and academic drug discovery, it appears crucial to 
federate efforts and resources through a national entity 
allowing rational, centralised investments for further ex-
pansion within Switzerland. Nationwide effort and coor-
dination are key, as a single university would not have 
the capacity or financial means to serve all the needs for 
academic screening in Switzerland.
An important part of the new centre will be a ‘Swiss 
Compound Library’, which collects, archives and makes 
available compound synthesised in Swiss academic lab-
oratories. A Swiss Chemical Collection2 (SCC) has been 
compiled in the NCCR. To this end, procedures were put in 
place for the collection of compounds (approx. 700) from 
seven organic chemistry groups, not commercially availa-
ble and atypical compared to the structural space covered 
by commercial libraries. The compounds were assayed 
in NCCR screens and profiled in cellular assays such as 
cell toxicity assays. The US National Institutes of Health 
(NIH) have similar, very successful facilities (NCATS). 
These facilities received well-deserved attention because 
they perfectly illustrate the added value of collections and 
because prominent researchers with otherwise unrelated 
interests were involved. Through the NIH facilities, un-
expected drug candidates for the treatment of cancer and 
neurodegenerative disease were identified. While the es-
sential contribution of high-throughput screening to such 
discoveries is not always highlighted, high-throughput 
screening is an imperative infrastructure for translational 
research.
The Swiss Compound Library will serve three main pur-
poses: First, it will archive ‘all’ molecules and their prop-
erties made in Swiss academia. Second, it will maximise 
added value for Swiss chemistry research by promoting 
the discovery of unexpected desirable activities by screen-
ing a unique chemical space. Third, the Swiss Compound 
Library will provide a unique tool to respond quickly to 
public health demands.
Aims of the Proposed Infrastructure
This project proposes the creation of a centre that will 
provide access to state-of-the-art instrumentation and ex-
pertise for translational chemistry research to the Swiss 
community. 
We propose the NCTC is built on the solid foundations of 
the existing screening facilities: the Biomelcular Screen-
ing Facility (BSF) created at EPFL in 2006 and further de-
veloped by the NCCR Chemical Biology (BSF-ACCESS) 
and the screening facility at the University of Geneva, AC-
CESS-Geneva created in 2015 by the same national con-
sortium. These two platforms have already started to work 
with partners in Switzerland beyond the local environ-
2 https://nccr-chembio.ch/technologies/facilities/the-swiss-chemical- 
collection
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ment of the Leman area. Planned investments are allocat-
ed to imaging screening facilities, automation and read-
out equipment, biosafety class 2 and 3 pathogen screening 
units, a chemogenomic and personalised medicine unit, 
management infrastructure for compound collections, 
and a medicinal chemistry laboratory.
It is a major aim of the project to further extend existing 
activities in the field of screening to develop a central-
ised and structured entity for sustainable drug discovery 
and research endeavours. The new entity will include 
the SCC, conceived to access a unique chemical space, 
to provide added value and to archive Swiss chemistry 
research. This infrastructure, focussing mostly on imag-
ing-based translational screening, is located downstream 
from the complementary mass spectrometry-oriented 
Screening Hub for Chemical Biology also proposed in 
this roadmap. An important developing area of applica-
tion concerns drug discovery for rare diseases or other 
diseases where treatments are not financially viable for 
the pharmaceutical industry. In the national interest we 
also aim at building specialised platforms to screen for 
pathogens and to address current public health issues and 
major challenges related to infectious diseases, such as 
pandemics from new viruses or the spread of pathogens 
resistant to antibiotics.
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Organisational scheme of the catalysis hub (Christope Copéret, ETH)
7�2�4 Catalysis Hub
Context (national and international), 
scientific rationale and challenges
Swiss chemical, agrochemical 
and pharmaceutical companies 
are world leaders in the transfor-
mation of petrochemical-based 
building blocks into complex molecules with high val-
ue. Irrespective of their target function, these compounds 
mostly originate from crude oil, a limited natural resource 
not available in Switzerland. Moreover, their production 
leads to increased levels of atmospheric carbon dioxide 
(CO2) and global warming. The use of natural resourc-
es available in Switzerland could allow Switzerland to 
decrease fossil-based petrochemical feedstocks with the 
ultimate goal to become carbon neutral. These natural 
resources include plentiful carbon in unused (inedible) 
waste biomass, hydrogen in water, and abundant renew-
able electricity, as well as alternative lower footprint car-
bon sources such as methane. The development of greener 
and novel catalytic processes and the usage of renewa-
ble energy sources such as hydro, solar or wind power 
to drive chemical reactions are key technologies to move 
from an oil-based economy to a sustainable economy for 
the production of fuels, feedstocks, fine chemicals and 
pharmaceuticals. 
In a global context, several high-level catalysis centres 
have been established over the last years to embrace this 
challenge (Merck Catalysis Centre at Princeton, UPenn/
Merck High Throughput Experimentation Laboratory, 
the Gordon and Betty Moore funded Centre for Cataly-
sis and Chemical Synthesis at Caltech, UK Catalysis Hub, 
joint Catalysis Research Laboratory of the University of 
Heidelberg that is supported by BASF (CaRLA) or the 
Netherlands Institute for Catalysis Research). Therefore, 
immediate action is required to maintain the internation-
ally-recognised quality of catalysis research in Switzer-
land at the highest competitive level. 
To achieve this goal, the ETH domain has just established 
a Catalysis Process Discovery Hub (Catalysis Hub – Cat+) 
co-based at ETH Zurich and EPFL that builds on the assets 
of the ETH domain and is open to the entire Swiss com-
munity. During the first phase of the Catalysis Hub (2021–
2024), catalysis research facilities with state-of-the-art 
high-throughput experimentation (HTE) equipment will 
be built at EPFL and ETH Zurich/Empa to provide access 
to advanced synthesis, characterisation, testing and opti-
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Set-up for high-throughput catalysist screening 
(photo Christope Copéret, ETH)
misation of catalysts, in both homogeneous and hetero-
geneous phases. High-throughput experimentation (HTE) 
has indeed emerged as an essential tool for catalyst dis-
covery and development enabling a rapid evaluation of 
multiple parameters, from catalyst composition to reac-
tion feeds and conditions. In parallel, machine learning 
and artificial intelligence have just emerged as powerful 
tools to investigate large parameter spaces. This research 
infrastructure thus has the goal to integrate high-through-
put experimentation and computational chemistry to-
gether with machine learning and Quantitative Structure 
Activity Relationships (QSAR) to discover catalysts and 
catalytic reactions with unprecedented efficiency, to ac-
celerate process development, and to revolutionise the 
way chemistry is performed. 
To invent rather than follow, we seek to build an unprece-
dented integrated infrastructure pairing the massive syn-
thesis and screening power of HTE and the most advanced 
characterisation tools with the advances of digital tech-
nology and future machine learning artificial intelligence 
in a Catalysis Hub designed to reinvent chemistry.
Aims of the Proposed Infrastructure
Most fine chemicals for the chemical and pharmaceutical 
industry are produced from oil using catalytic processes. 
The goal of this ETH domain hub is to build on the ETH 
domain combined excellence in chemistry and chemical 
engineering to make possible the use of renewable ener-
gy, CO2/H2O and waste biomass to produce synthetic fuels 
and feedstock chemicals. The necessary key ingredient is 
the reinvention of chemistry, based in particular on catal-
ysis, to move away from simple petrochemical feedstocks 
and to access more value-added fine chemicals. To accel-
erate the discovery process and the transfer of technology, 
we propose integrated cross-cutting research approaches: 
computer guided automated synthesis, characterisation 
and continuous-flow evaluation of massive catalyst li-
braries, and computational approaches through a Catal-
ysis Process Discovery Hub that pools capacities across 
the entire ETH domain. This goes well beyond research 
undertaken within the existing competence centres of the 
ETH domain, such as SFA Energy Research or SCCER pro-
grammes. Combining computational and high-through-
put catalyst discovery with machine learning will lead to 
breakthroughs in catalytic and sustainable processes. The 
key ultimate goals include:
 – The development of artificial intelligence-based dis-
covery approaches in catalysis based on high-through-
put experimentation combined with a machine-learn-
ing artificial intelligence approach in order to accelerate 
discovery and guide to unexpected solutions
 – The development of in situ and operando spectroscop-
ic tools and methods with unprecedented resolution, 
together with computational methods, to drive the ra-
tional design of novel and improved catalysts and to 
understand how to overcome limitations such as cata-
lyst stability/deactivation.
 – The development of highly efficient, novel catalysts, 
processes and catalysis concepts for conversion of 
abundant feedstocks into high-value compounds.
 – The discovery of novel catalytic processes that will al-
low the rapid synthesis of highly complex molecules 
and smart materials in a highly efficient and sustaina-
ble way. 
Catalysis Hub – Cat+ is located on two campuses in the 
East and the West of Switzerland to best exploit world-
class expertise in both locations. Each of them will con-
centrate on specific and complementary topics: solid 
(heterogeneous) catalysts in the East and molecular (ho-
mogeneous) catalysts in the West, based on the respective 
existing critical expertise. This platform will be open to 
the entire Swiss community, both from academia and in-
dustry, and will guarantee a rapid access to the state-of-
the-art research infrastructure in catalysis.  
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8 Conclusions
This Chemistry Roadmap proposes the discovery-driven and challenge-driven research infrastructures 
(RI) that are required to keep the Swiss chemistry community in academia and in industry at the forefront 
of international research in the chemical sciences. The proposed infrastructures will enable scientists to 
translate knowledge into solutions for the current global challenges in energy, environment, health and 
sustainability.
The Swiss chemistry community has realised the necessity to join forces and to collectively install frontier 
instrumentation at a higher level than is possible by individual university units. The community underlines 
the need for national infrastructures in order to enable access to state-of-the-art large instrumentation 
and expertise that can no longer be hosted by single institutions. Moreover, these facilities should provide 
inter- and transdisciplinary support and expertise to users to improve data acquisition and analysis, one 
of the key challenges in chemical research and a necessary step toward improving scientific quality and 
in moving towards quality open data.
Seven key enabling infrastructures have been identified, three discovery-driven research infrastructures 
and four challenge-driven research infrastructures.
Discovery-driven research infrastructures:
 Æ Discovery RI-1) A magnetic resonance and magnetism hub
 Æ Discovery RI-2) A centre for operando synchrotron studies
 Æ Discovery RI-3) An electron microscopy and diffraction hub
Challenge-driven research infrastructures:
 Æ Challenge RI-1) A facility to produce Terbium radionuclides for diagnostics and treatment of disease
 Æ Challenge RI -2) A mass spectrometry-based screening platform for (bio)catalysts and environmen-
tal samples
 Æ Challenge RI -3) A centre that provides state-of-the-art instrumentation for translational chemistry 
and manages a national library of compounds synthesised in academic laboratories across Swit-
zerland
 Æ Challenge RI -4) A catalysis hub (CAT+) to discover and develop catalysts and catalytic processes 
towards a sustainable society
The infrastructures proposed in this Chemistry Roadmap for Research Infrastructures will build on exist-
ing Swiss expertise and aim to be tightly linked to other community roadmaps, namely the Photon Science 
Roadmap, the Neutron Science Roadmap and the Biology Roadmap. The ultimate goal is to provide unique 
world class facilities to the Swiss and international science community. As a result, Switzerland will remain 
attractive and innovative in chemical sciences, one of the key assets of Switzerland at the international 
level, and an essential component for a sustainable development of Switzerland.
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SCNAT – network of knowledge for the benefit of society
The Swiss Academy of Sciences (SCNAT) and its network of 35,000 experts works at regional, national and interna-
tional level for the future of science and society. It strengthens the awareness for the sciences as a central pillar of 
cultural and economic development. The breadth of its support makes it a representative partner for politics. The 
SCNAT links the sciences, provides expertise, promotes the dialogue between science and society, identifies and 
evaluates scientific developments and lays the foundation for the next generation of natural scientists. It is part of 
the association of the Swiss Academies of Arts and Sciences..

